Author

Alban Vigroux

Université Côte d'Azur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adèle RivaultiD· 1 shared Anthony R. MartiniD· 1 shared Arnaud JacqueliD· 1 shared Arnaud PoterszmaniD· 1 shared Catherine BirckiD· 1 shared Cécile Favreau· 1 shared Coline Savy· 1 shared Emeline KerreneuriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adèle RivaultORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis

Cécile Favreau, Maxence Bourgoin, Coline Savy, Thomas Botton, Sarah Bailly, Florence Granger, Catherine Birck, Marwa Zerhouni, Emeline Kerreneur, Adèle Rivault, Alban Vigroux, Jade Dussart‐Gautheret, Marie-Laure Arcangeli, Arnaud Poterszman, Thomas Cluzeau, , Guillaume Robert

The paper identifies two compounds that target GPX4 and TXNRD1 to induce apoptosis and ferroptosis in AML cells, effectively eradicating malignant cells while sparing normal hematopoietic cells.

Experimental Hematology and Oncology · Mar 31, 2026Peer-reviewedBiochemistry